Below are fake online pharmacies that offer potentially dangerous unapproved and misbranded prescription drugs to U.S. consumers. FDA has issued warning letters informing the website operators that they are engaged in illegal activity in violation of the U.S. Federal Food, Drug, and Cosmetic Act (FD&C Act). Violations may include, but are not limited to, the following: offering for sale unapproved prescription drugs of unknown origin, safety, and effectiveness; offering prescription drugs without a prescription; offering prescription drugs without adequate directions for safe use; and offering prescription drugs without FDA-required warnings to consumers about the serious health risks associated with the prescription drug. Buying prescription drugs from fake online pharmacies can be dangerous, or even deadly to consumers. FDA recommends that consumers do not purchase prescription drugs from the websites listed below and that consumers understand the risks of buying prescription drugs online. A legal internet pharmacy must be licensed in the state(s) in which they are operating, all states to which they do business, and there must be a state-licensed pharmacist on staff.
The websites listed in the warning letters below do not represent an all-inclusive list of illegally-operating online pharmacies. The absence of a warning letter does not indicate that a website is operating legally and offering FDA-approved safe and effective prescription drugs for sale to U.S. consumers. Please see the link below to learn more about buying prescription drugs safely over the Internet.
To learn more about the dangers of buying prescription drugs on the Internet and how to buy online safely, see FDA's BeSafeRx Campaign.
To report a complaint about a pharmacy website, see "Reporting Unlawful Sales of Medical Products on the Internet."
If there are questions regarding the content of this page, email the FDA Internet Pharmacy Task Force at FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov.
|Name of Warning Letters |
* A Warning Letter is issued when FDA has determined a website violates the FD&C Act.
|Issue Date||Close-Out Date|
* When a website corrects all of the violations contained in FDA's warning letter, FDA will issue a close-out letter. This close-out letter does not relieve the website of responsibility for taking all necessary steps to assure continued compliance with the FD&C Act or other relevant legal authority. Additionally, this close-out letter does not ensure that the website will continue to operate legally after its issuance, nor does it prevent future regulatory action should violations be discovered.
|Global Drug Supply||December 2016|
|Steroid Bazaar||June 2016|
|Shop Anabolics||June 2016|
|Rx Partners||June 2015|
|Meds India Ltd||June 2015|
|Discount Online Pharmacy||February 2013|
|Secure Medical Inc.||February 2013|
|Sun Drug Store||February 2013|
|Big Mountain Drugs||February 2013|
|Pronet/Eyal Bar Oz||September 2012|
|Arkadiy Kisin/White Forest Solutions||September 2012|
|Marks Marine Pharmacy||August 2012|
|Best Price Rx||May 24, 2012||Best Price Rx Letter|
|Northwest Pharmacy||May 24, 2012||Northwest Pharmacy Letter|
|Galyna/Ivan Podornikova||September 2011|